Patents by Inventor Zuobai WANG

Zuobai WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12103974
    Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that bind to human OX40 (ACT35, CD134, or TNFRSF4), a pharmaceutical composition comprising said antibody, and use of the antibody or the composition for treating a disease, such as cancer. In particular, the anti-OX40 antibody of the present invention does not interfere with the binding of OX40-ligand to its receptor.
    Type: Grant
    Filed: May 22, 2019
    Date of Patent: October 1, 2024
    Assignee: BEIGENE, LTD.
    Inventors: Ye Liu, Tong Zhang, Zuobai Wang, Kang Li
  • Publication number: 20210214452
    Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that bind to human OX40 (ACT35, CD134, or TNFRSF4), a pharmaceutical composition comprising said antibody, and use of the antibody or the composition for treating a disease, such as cancer. In particular, the anti-OX40 antibody of the present invention does not interfere with the binding of OX40-ligand to its receptor.
    Type: Application
    Filed: May 22, 2019
    Publication date: July 15, 2021
    Inventors: Ye LIU, Tong ZHANG, Zuobai WANG, Kang LI